Benefits of Genomic Testing in Immuno-oncology Clinical Trials

The Benefits of Incorporating Genomic Testing into Immuno-oncology Clinical Trials

In this video, Victor Weigman, Ph.D., Director, Translational Genomics discusses how incorporating genomic testing facilitates research and clinical trial design to realize genomics-based medicine. You’ll also learn how genomic testing expands insight into more treatment options based on a patient’s tumor classification.

More Resources

4 Ways Central Laboratories Shape Immuno-oncology Drug Development
The Pivotal Roles Genomics and Flow Cytometry Play in Immuno-oncology Clinical Development
Proven Benefits of Gene Expression Profiling for Biomarker Discovery in Immunotherapy Trials
View All